Photodynamic therapy using TLD-1433 represents a viable treatment option for BCG-unresponsive NMIBC CIS with an acceptable safety profile. Light-activated TLD-1433 photodynamic therapy (PDT ...

They developed light-sensitive chemicals, called cyanine-carborane salts, that are used in photodynamic therapy (PDT). They destroy metastatic breast cancer tumors. Currently, the research has ...

Chairman and CEO Dr. Christopher Schaber joined IBN's BioMedWire Podcast to discuss the company's two-pronged business ...

Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company, is advancing its phase 3 replication study (“FLASH2”) for HyBryte(TM), a novel pho ...

The BioMedWire Podcast delivers dynamic interviews with industry experts at the forefront of pharmaceutical and biotech ...

This process converts light energy into chemicals ... these reactions can also be used for therapeutic purposes, such as photodynamic therapy to target tumor cells or pathogens.

This process converts light energy into chemicals ... these reactions can also be used for therapeutic purposes, such as photodynamic therapy to target tumor cells or pathogens.

Far from doffing their caps to actinic keratosis (AK), dermatology drug developers Almirall and Biofrontera are keeping ...

Chairman and CEO Dr. Christopher Schaber joined IBN’s BioMedWire Podcast to discuss the company’s two-pronged business model, robust late-stage pipeline, and ongoing clinical trials. Schaber ...